Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2000-04-06

Original market date: See footnote 1

1961-12-31

Product name:

POLIOVIRUS VACCINE LIVE ORAL TRIVALENT

DIN:

00075043 Electronic product monograph is not available

Company:

AVENTIS PASTEUR LIMITED
1755 Steeles Avenue West
Toronto
Ontario
Canada M2R 3T4

Class:

Human

Dosage form(s):

Suspension

Route(s) of administration:

Oral

Number of active ingredient(s):

3

Schedule(s):

Schedule D

 

American Hospital Formulary Service (AHFS): See footnote 3

80:12.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

J07BF02 POLIOMYELITIS ORAL, TRIVALENT, LIVE ATTENUATED

Active ingredient group (AIG) number:See footnote5

0319633002

List of active ingredient(s)
Active ingredient(s) Strength
POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-1 1000000 UNIT / DOSE
POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-2 100000 UNIT / DOSE
POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-3 300000 UNIT / DOSE
Version 4.0.2
Date modified: